MMP-2 Inhibitors

MMP-2/MMP-3 Inhibitor I exhibits a selective binding affinity for MMP-2, engaging in specific hydrogen bonding and hydrophobic interactions that stabilize the enzyme's inactive conformation. Its unique structural features facilitate a competitive inhibition mechanism, effectively altering the enzyme's catalytic efficiency. The compound's dynamic behavior in solution highlights its potential for conformational adaptability, allowing for fine-tuning of its interaction with MMP-2 substrates.

MMP Inhibitor III (CAS 927827-98-3) effectively inhibits MMP-2, a key enzyme in cellular processes. By regulating MMP-2 activity, it influences specific cellular functions.

Chlorhexidine, Dihydrochloride (CAS 3697-42-5) functions as an inhibitor of MMP-2, a key enzyme in cellular processes. It regulates MMP-2 activity, impacting specific cellular functions.

Isobavachalcone (CAS 20784-50-3) acts as an inhibitor of MMP-2, a crucial enzyme in cellular processes. By modulating MMP-2 activity, it influences specific cellular functions.

NSC 405020 is a compound known to inhibit MMP-2 activity. By disrupting MMP-2's enzymatic function, NSC 405020 may play a role in controlling processes involving matrix remodeling, such as tissue repair and cancer metastasis.

MMP-2/MMP-9 Inhibitor I demonstrates a remarkable ability to modulate the activity of MMP-2 through intricate molecular interactions. Its design incorporates specific functional groups that enhance binding through electrostatic and van der Waals forces, promoting a stable enzyme-inhibitor complex. The inhibitor's kinetic profile reveals a slow dissociation rate, suggesting prolonged engagement with the target, which may influence downstream signaling pathways and cellular responses.

PD166793 is a selective MMP-2 inhibitor that works by binding to the active site of the enzyme. This interaction prevents MMP-2 from degrading extracellular matrix components, which could be beneficial in conditions where matrix remodeling is dysregulated.

UK-356618 is a synthetic inhibitor of MMP-2 that targets the enzyme's active site. Its mechanism of action involves blocking MMP-2's ability to degrade extracellular matrix components, which could have therapeutic implications in conditions involving matrix remodeling.

CP 471474 exhibits a unique mechanism of action as an MMP-2 inhibitor, characterized by its selective binding affinity. The compound's structural features facilitate strong hydrogen bonding and hydrophobic interactions with the enzyme's active site, leading to a significant reduction in proteolytic activity. Its reaction kinetics indicate a competitive inhibition model, where the inhibitor effectively competes with substrate binding, thereby altering the enzymatic turnover rate and influencing matrix remodeling processes.

ONO-4817 is an MMP-2 inhibitor that acts by binding to the enzyme's active site. Its mechanism of action involves interfering with MMP-2's ability to degrade extracellular matrix components, which could be relevant in pathological conditions involving matrix remodeling.